Epilepsia Partialis Continua and Generalized Nonconvulsive Status Epilepticus during the Course of Argininemia: A Report on Two Cases

Abstract

Argininemia is a rare inherited disorder of the urea cycle because of a deficiency of the enzyme arginase I causing an increase of arginine and guanidino compounds in the blood, urine, and cerebrospinal fluid. The clinical picture is characterized by a mild cognitive dysfunction, progressive asymmetrical paraparesis, and seizures. Here, we describe two cases of argininemia where either epilepsia partialis continua (EPC) or nonconvulsive status epilepticus (NCSE) were the presenting manifestations of epilepsy. This is the first report of EPC in an urea cycle disorder. In both the cases, status epilepticus resolved with anticonvulsive drugs. EPC was successfully treated with levetiracetam, and NCSE with valproic acid. No side effects were observed. Because hyperammonemia and NCSE may have the same features of stupor, a neurophysiological approach might prove useful in differentiating these two conditions. Overall, our results strongly indicate that a correct NCSE diagnosis is mandatory to prevent further deterioration in these patients.

Keywords

argininemia - epilepsia partialis continua - status epilepticus - urea cycle disorders - levetiracetam - valproic acid

• References

• 1 Terheggen HG, Schwenk A, Lowenthal A, Van Sande M, Colombo JP. Argininaemia with arginase deficiency. [letter] Lancet 1969; 294 (7623) 748-749
• 2 Terheggen HG, Schwenk A, Lowenthal A , et al. Hyperargininemia with arginase deficiency. A new familial metabolic disease. I. Clinical Studies. Z Kinderheilkd. 1970; 107 (4) 298-312
• 3 Vilarinho L, Senra V, Vilarinho A , et al. A new case of argininaemia without spastic diplegia in a Portuguese male. J Inherit Metab Dis 1990; 13 (5) 751-752
• 4 Christmann D, Hirsch E, Mutschler V, Collard M, Marescaux C, Colombo JP. Late diagnosis of congenital argininemia during administration of sodium valproate. Rev Neurol (Paris) 1990; 146 (12) 764-766
• 5 Carvalho DR, Brum JM, Speck-Martins CE , et al. Clinical features and neurologic progression of hyperargininemia. Pediatr Neurol 2012; 46 (6) 369-374
• 6 Kozevnikov AY . A peculiar type of cortical epilepsy (epilepsia corticalis sive partialis continua). Miditsinskoe Obozreni 1894;42/14:33–62. Asher DM, trans-ed. Chronic encephalitis and epilepsy. In: Andermann F, , ed. Rasmussen's Syndrome. Boston, MA: Butterworth-Heinemann; 1991: 245-61
• 7 Engel Jr J. Report of the ILAE Classification Core Group. Report of the ILAE classification core group. Epilepsia 2006; 47 (9) 1558-1568
• 8 Bien CG, Elger CE. Epilepsia partialis continua: semiology and differential diagnoses. Epileptic Disord 2008; 10 (1) 3-7
• 9 Glauser TA, Cnaan A, Shinnar S , et al; Childhood Absence Epilepsy Study Team. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia 2013; 54 (1) 141-155
• 10 Scaglia F, Lee B. Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency. Am J Med Genet C Semin Med Genet 2006; 142C (2) 113-120
• 11 Carvalho DR, Farage L, Martins BJ, Brum JM, Speck-Martins CE, Pratesi R. Brain MRI and magnetic resonance spectroscopy findings in patients with hyperargininemia. J Neuroimaging 2012; (e-pub ahead of print) doi: 10.1111/j.1552-6569.2012.00739x
• 12 Patay Z. Metabolic disorders. In: Tortori-Donati P, Rossi A, , eds. Pediatric Neuroradiology: Brain, Head, Neck and Spine. Berlin Heidelberg, Germany: Springer-Verlag; 2005. :Chap 13, pp. 544-721